GlassScriptPhysician profile
Kent Remley
NPI 1114994605
$1,966.28
in general payments reported to CMS, 2019-2025
27 companies · $23.31 in 2025
The $23.31 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,769 · 2020: $174 · 2025: $23.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $596.94 | 2019 | |
| Nevro Corp. | $309.69 | 2019 | |
| Stimwave Technologies Incorporated | $265.73 | 2019 | |
| Spr Therapeutics, INC | $159.67 | 2019-2020 | |
| Avanos Medical | $104.50 | 2019 | |
| Kaleo, INC. | $65.01 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.88 | 2019 | |
| Collegium Pharmaceutical, INC. | $44.68 | 2019 | |
| Assertio Therapeutics, INC. | $41.37 | 2019 | |
| Tersera Therapeutics LLC | $37.14 | 2019 | |
| Radius Health, INC. | $26.74 | 2019 | |
| Biotronik Nro, INC. | $23.31 | 2025 | Prospera |
| Teva Pharmaceuticals USA, INC. | $21.09 | 2019 | |
| Scilex Pharmaceuticals INC. | $20.79 | 2019 | |
| Pfizer INC. | $18.01 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $17.79 | 2019 | |
| Promius Pharma LLC | $17.72 | 2019 | |
| Abbott Laboratories | $16.63 | 2019 | |
| Horizon Therapeutics Plc | $16.04 | 2019 | |
| Upsher-Smith Laboratories LLC | $15.14 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.78 | 2019 | |
| Pacira Therapeutics, INC. | $14.55 | 2019 | |
| Vertiflex, INC. | $13.96 | 2019 | |
| Amgen INC. | $13.80 | 2019 | |
| Biodelivery Sciences International, INC. | $12.69 | 2019 | |
| Lilly USA, LLC | $11.13 | 2019 | |
| Electronic Waveform Lab, INC. | $10.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Remley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.